Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. (Q42500788)
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. |
scientific article |
Statements
1 reference
Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. (English)
1 reference
Pollak MN
1 reference
Polychronakos C
1 reference
Guyda H
1 reference
1 July 1989
1 reference
1 reference
9
1 reference
4
1 reference
889-891
1 reference
Identifiers
1 reference